HNCFX | RERGX | HNCFX / RERGX | |
Total Expense Ratio | 0.85 | 0.47 | 181% |
Annual Report Gross Expense Ratio | 0.89 | 0.47 | 189% |
Fund Existence | 9 years | 16 years | - |
Gain YTD | 19.668 | 16.046 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 342M | 133B | 0% |
Annual Yield % from dividends | 0.43 | 0.93 | 47% |
Returns for 1 year | 20.06 | 9.06 | 221% |
Returns for 3 years | 65.89 | 36.53 | 180% |
Returns for 5 years | 29.79 | 13.26 | 225% |
Returns for 10 years | N/A | 42.19 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETCHX | 35.44 | 0.44 | +1.26% |
Eventide Healthcare & Life Sciences C | |||
CFSLX | 11.91 | 0.04 | +0.34% |
Column Small Cap | |||
RGAAX | 75.24 | 0.18 | +0.24% |
American Funds Growth Fund of Amer R1 | |||
FGRAX | 52.35 | -0.01 | -0.02% |
Franklin Growth Opportunities A | |||
MIOFX | 30.28 | -0.01 | -0.03% |
Marsico International Opportunities |